NO902861L - Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav. - Google Patents

Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav.

Info

Publication number
NO902861L
NO902861L NO90902861A NO902861A NO902861L NO 902861 L NO902861 L NO 902861L NO 90902861 A NO90902861 A NO 90902861A NO 902861 A NO902861 A NO 902861A NO 902861 L NO902861 L NO 902861L
Authority
NO
Norway
Prior art keywords
lower alkyl
naphythyloxypyridamines
naftylamino
procedures
preparing
Prior art date
Application number
NO90902861A
Other languages
English (en)
Other versions
NO902861D0 (no
Inventor
Richard Charles Effland
Joseph Thomas Klein
Gordon Edward Olsen
Larry Davis
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO902861D0 publication Critical patent/NO902861D0/no
Publication of NO902861L publication Critical patent/NO902861L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er beskrevet forbindelser av formelen. hvor. X er 0 eller NR, Rer hydrogen, laverealkyl eller. laverealkylkarbonyl,. Y er hydrogen, laverealkyl, laverealkoksy, halogen. eller trifluormetyl,. Z er KOeller NHE, hvor R er hydrogen, laverealkyl,. aryllaverealkyl eller laverealkylkarbonyl, og. n er 0 eller 1, under den forutsetning at n er 0 når Z. er NHR,. og en fremgangsmåte for fremstilling av forbindelsene.Forbindelsene er nyttige som topiske antiinflamma-torlske midler for behandling av hudsykdommer.
NO90902861A 1989-06-28 1990-06-27 Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav. NO902861L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90/002767A US4931457B1 (en) 1989-06-28 1989-06-28 Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders

Publications (2)

Publication Number Publication Date
NO902861D0 NO902861D0 (no) 1990-06-27
NO902861L true NO902861L (no) 1991-01-02

Family

ID=23468431

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902861A NO902861L (no) 1989-06-28 1990-06-27 Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav.

Country Status (12)

Country Link
US (1) US4931457B1 (no)
EP (1) EP0405426A3 (no)
JP (1) JPH0338567A (no)
KR (1) KR910000647A (no)
AU (1) AU5784790A (no)
CA (1) CA2019624A1 (no)
FI (1) FI903214A0 (no)
IE (1) IE902330A1 (no)
IL (1) IL94876A0 (no)
NO (1) NO902861L (no)
PT (1) PT94502A (no)
ZA (1) ZA905001B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
TW200462B (no) * 1990-09-27 1993-02-21 Hoechst Roussel Pharma
US5581010A (en) * 1994-07-22 1996-12-03 Rockwell International Corporation Semi-organic crystals for nonlinear optical devices
RU2203272C2 (ru) * 1997-02-21 2003-04-27 Байер Акциенгезелльшафт Замещенные бициклические соединения, исходные и промежуточные продукты для их получения и фармацевтическая композиция на их основе
DE19740785A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Arylsulfonamide und Analoga
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3118884A (en) * 1959-10-19 1964-01-21 Schering Corp Derivatives of 3-azaphenothiazine and 3-azaphenoxazine
US3495969A (en) * 1967-09-25 1970-02-17 Mobil Oil Corp Substituted nitropyridines as herbicides
US3576616A (en) * 1969-05-15 1971-04-27 Monsanto Co Herbicidal compositions and methods
US3721676A (en) * 1969-11-12 1973-03-20 Merck & Co Inc Certain 3-amino-2(1h)pyridones
EP0000816A1 (en) * 1977-08-06 1979-02-21 Beecham Group Plc Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
GB2073736B (en) * 1979-10-03 1984-02-01 Ici Ltd Process for preparing pyridinyloxyphenoxy compounds and derivatives thereof
US4521426A (en) * 1982-09-30 1985-06-04 Union Carbide Corporation Pesticidal bicyclooxyheterocyclyl aroyl ureas
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds

Also Published As

Publication number Publication date
US4931457B1 (en) 1993-11-16
EP0405426A2 (en) 1991-01-02
IE902330A1 (en) 1991-01-16
JPH0338567A (ja) 1991-02-19
IE902330L (en) 1990-12-28
NO902861D0 (no) 1990-06-27
CA2019624A1 (en) 1990-12-28
KR910000647A (ko) 1991-01-29
AU5784790A (en) 1991-01-03
US4931457A (en) 1990-06-05
PT94502A (pt) 1991-02-08
EP0405426A3 (en) 1992-05-13
IL94876A0 (en) 1991-04-15
FI903214A0 (fi) 1990-06-26
ZA905001B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
FI890931A (fi) Menetelmä 5-lipoksigenaasia inhiboivien 4-(4-fenyyli-1-piperatsinyyli)fenoleiden valmistamiseksi
DE60037892D1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
GEP20032913B (en) Thienylazolylalcoxyethanamines, Their Preparation and Their Application as Medicaments
NO902861L (no) Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav.
ES2123652T3 (es) 7-(2-aminoetil)-benzotiazolonas.
NO885714L (no) Fremgangsmaate for fremstilling av propoksybenzenderivater.
NO913331L (no) 4-substituerte dihydropyrido(4,3-d)pyrimidiner for behandling av hudforstyrrelser.
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
JPS5424872A (en) Imidazole derivatives, their preparation, and agricultural and horticultural fungicides
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
DK0420224T3 (da) Anthihepatopatisk middel
AR246511A1 (es) Acido 2-azabiciclo (2.2.1)hept-5-eno-2-acetico y derivados del mismo, procedimiento para su preparacion y procedimiento para preparar n-fosfonometilglicina con los mismos.
NO303686B1 (no) Forbindelse til anvendelse ved fremstilling av alkylderivater av trazodon med CNS-aktivitet
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE121623T1 (de) Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
JPS5239674A (en) Imidazole derivatives and agricultural bactericides therefrom
JPS532473A (en) N-3-pyridyl-n#-phenylamidine derivatives, method of preparing same, and fungicides for agriculture and gardening use
TH893EX (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
TH893A (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
TH4659EX (th) เพอร์ไฮโดรไธอะเซฟีนและอนุพันธ์ต่างๆ ของเพอร์ไฮโดรอะเซฟีน การเตรียมและการใช้สารเหล่านี้สำหรับรักษาโรค
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้